Pfizer (PFE) Land & Improvements (2009 - 2011)

Pfizer (PFE) has 3 years of Land & Improvements data on file, last reported at $747.0 million in Q4 2011.

• Land & Improvements for Q4 2011 came in at $747.0 million, down 5.56% year-over-year; the trailing twelve-month figure through Dec 2011 was $747.0 million (down 5.56% YoY), and the FY2011 annual result was $747.0 million, down 5.56% from the prior year.
• Land & Improvements eased to $747.0 million in Q4 2011 per PFE's latest filing, from $791.0 million in the prior quarter.
• Over five years, Land & Improvements peaked at $937.0 million in Q4 2009 and troughed at $747.0 million in Q4 2011.
• A 3-year average of $825.0 million and a median of $791.0 million in 2010 frame the typical range for Land & Improvements.
• The sharpest annual moves came in 2010 and 2011: Land & Improvements fell 15.58% in 2010, then dropped 5.56% in 2011.
• A 3-year view of Land & Improvements shows it stood at $937.0 million in 2009, then decreased by 15.58% to $791.0 million in 2010, then slipped by 5.56% to $747.0 million in 2011.
• Business Quant data shows PFE's Land & Improvements at $747.0 million in Q4 2011, $791.0 million in Q4 2010, and $937.0 million in Q4 2009.